PREVALENCE AND DETERMINANTS OF DIABETES DISTRESS AMONG TYPE 2 DIABETES MELLITUS (T2DM) WITH INSULIN THERAPY IN A PRIMARY HEALTH CARE CENTRE

Abstract

Individuals with diabetes mellitus experience psychological issues associated with their disease and involve multiple states related to diabetes management. Insulin distress is a significant contributor to diabetes distress. The objective of this study is to identify the prevalence and determinants of diabetes distress among type 2 Diabetes Mellitus (T2DM) with insulin therapy in the setting of primary health care. Methods: This cross-sectional study was conducted from 1st August 2022 to 30th December 2022 at Sungai Buloh Health Clinic, Selangor, Malaysia. 300 T2DM with insulin therapy were recruited and screened for diabetes distress status. Their sociodemographic and relevant medical profiles were recorded, and the Diabetes Distress Scale (DDS) was used to measure diabetes distress. Results: Diabetes distress was prevalent among insulin respondents at a rate of 24.3%, with 13.2% of patients experiencing emotion-related distress, 7.7% experiencing regimen-related distress, 2.3% experiencing interpersonal-related distress, and 1.1% experiencing physician-related diabetes distress.The significant determinants for diabetes distress among diabetic cases were education with (OR = 0.248, 95% CI: 0.116-2.101), diabetes duration (OR = 0.415, 95% CI: 0.235- 0.735), exercises (OR = 17.91, 95% CI: 2.337-137.32), FBS (OR = 0.517, 95% CI: 0.283- 0.945), HbA1c (OR = 2.774, 95% CI: 1.249-6.159).Conclusion: The present study shows that diabetes distress prevalence is present among T2DM with insulin therapy. Then, suggested components of diabetes distress should be implemented as screening strategies among T2DM with insulin therapy to prevent the late detection of psychiatric disorders. The study highlights comprehensive planning, holistic collaboration, and integrated strategies to improve patient adherence and health outcomes.